In China, Rare Dissent Over a Program to Save on Drug Costs

The New York Times – Business:

Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.

This post first appeared in The New York Times – Business. Read the original article.